Hemolytic-uremic syndrome
MONDO:0001549Acute kidney injury associated with microangiopathic hemolytic anemia and thrombocytopenia.
Also known as: HUS, hemolytic uremic syndrome, acute renal failure, thrombocytopenia, and microangiopathic hemolytic anaemia associated with distorted erythrocytes ('burr cells'), acute renal failure, thrombocytopenia, and microangiopathic hemolytic anemia associated with distorted erythrocytes ('burr cells')
27 clinical trials for this condition and its sub-types, 7 tagged with Hemolytic-uremic syndrome itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Hemolytic-uremic syndrome
-
Hereditary hemolytic uremic syndrome 0 trials · 19 incl. sub-types
2 sub-types
-
Infection-related hemolytic uremic syndrome 0 trials · 2 incl. sub-types
2 sub-types
Most studied deeper sub-types
-
Could more water save Kids' kidneys? new trial tests simple IV strategy
Disease control Recruiting nowThis study tests whether giving children with a severe E. coli infection extra fluids through an IV can prevent kidney failure. About 1,040 children aged 9 months to 21 years will take part. The goal is to see if this simple approach reduces the need for dialysis or long-term kid…
Sponsor: University of Calgary • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New antitoxin aims to speed kidney recovery in kids with e. coli infection
Disease control Recruiting nowThis study tests a new medicine called INM004 in 220 children with hemolytic uremic syndrome (HUS) caused by E. coli bacteria. The goal is to see if it helps the kidneys recover faster and reduces the need for dialysis. Participants are children aged 9 months to 18 years who have…
Phase 3 • Sponsor: Inmunova S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Blood test could unlock precision medicine for deadly TMA
Diagnosis Recruiting nowThis study is testing a new blood test (the HMEC test) to see if it can better identify which patients with thrombotic microangiopathy (TMA) have a specific immune system problem driving their disease. TMA is a severe condition that damages kidneys and the brain. The researchers …
Sponsor: Maastricht University Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
Scientists seek samples to build better Cancer-Killing drugs
Knowledge-focused Recruiting nowThis study collects blood, urine, bone marrow, and tumor samples from people with hairy cell leukemia and other blood cancers, as well as from healthy volunteers. Researchers will use these samples to study the diseases and develop new treatments called immunotoxins, which use an…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC